H1N1 vaccine isn't linked to higher risk of Guillain-Barre syndrome

04/14/2010 | HealthDay News

Researchers found no significant difference in the incidence of the rare neurodegenerative disorder Guillain-Barre syndrome between those who were vaccinated against the H1N1 flu virus and the general population. The finding "makes vaccination the first-line strategy for infection prevention," one of the researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT